Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05325996 · ClinicalTrials.gov registry record · NA
Evaluating Home Testing Devices for the Management of Glaucoma
A NA study of Glaucoma Open-Angle, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT05325996: Completed NA study of Glaucoma Open-Angle, sponsored by Wills Eye.
NCT05325996 is a NA study of Glaucoma Open-Angle that has completed, run by Wills Eye. The registered enrollment target is 53 participants, below the 163-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05325996, a NA study of Glaucoma Open-Angle, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with head mounted perimetry; detection of progression with head mounted perimetry vs office based perimetry; and monitoring the eye pressure measured by patients at home using a portable tonometer.
Primary Outcome
The visual field measures sensitivity of the retina to light at several locations in the peripheral vision. The difference of mean of these measurements compared to a normal database is presented in negative or positive values called mean deviation. Visual field mean deviation (MD) (light measurement in decibels in multiple spots across the central and peripheral retina known as entire visual field) will be captured by VisuALL per eye once a week during a 2 year period at participant's home.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Standard Automatic Perimetry Humphrey Field Analyzer
- DIAGNOSTIC_TEST visuALL H
- DIAGNOSTIC_TEST iCare Home Tonometer
- DIAGNOSTIC_TEST Spectralis Optical coherence tomography (OCT)
Study Locations (1)
Pennsylvania
- Wills Eye Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2025-02-17 |
| Phase | NA |
What the finished NCT05325996 record still lists
NCT05325996 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 163-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Glaucoma Open-Angle appearing as the primary indexed condition, and to 4 interventions - of which Standard Automatic Perimetry Humphrey Field Analyzer is the first listed.
NCT05325996 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05325996 about?
NCT05325996 is a clinical study titled "Evaluating Home Testing Devices for the Management of Glaucoma". With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with head mounted perimetry; detection of progression with head mounted perimet...
What is the current status of trial NCT05325996?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2022-04-15. Estimated completion is 2025-02-17.
What conditions does trial NCT05325996 study?
This clinical trial studies the following conditions: Glaucoma Open-Angle.
What interventions are being tested in trial NCT05325996?
The interventions under investigation include: Standard Automatic Perimetry Humphrey Field Analyzer (DIAGNOSTIC_TEST), visuALL H (DIAGNOSTIC_TEST), iCare Home Tonometer (DIAGNOSTIC_TEST), Spectralis Optical coherence tomography (OCT) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05325996?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05325996 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma Open-Angle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05325996's enrollment target sits among peer trials
53 18th of 22 higher than 5 of 22 other Glaucoma Open-Angle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma Open-Angle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Optic Nerve Head Strain as Biomarker for Glaucoma
RECRUITING · NA
-
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
RECRUITING · NA
-
A Trial of Hydrus Microstent Versus Goniotomy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI